Skip to main content
SpringerLink
Log in

The Role of Echocardiography in Hypertrophic Cardiomyopathy

  • Echocardiography (JM Gardin, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Hypertrophic cardiomyopathy (HCM) is a disease with a constellation of unique clinical, hemodynamic and echocardiographic features. Over the past decades, echocardiography has played a pivotal role in our understanding of the epidemiology, pathophysiology and prognosis of the condition. Recent advances in echocardiographic techniques have not only expanded our knowledge base but have also extrapolated the role of imaging from that of diagnosis, screening and non-invasive serial assessment to identification of poor prognostic markers, differentiation from phenocopies of HCM and guidance of intraprocedural decision-making in both septal ethanol ablation and surgical myectomy. This article summarizes the recent advances in echocardiography pertaining to HCM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Drinko JK, Nash PJ, Lever HM, Asher CR. Safety of stress testing in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2004;93(11):1443–4. A12.

    Article  PubMed  Google Scholar 

  2. Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124(24):e783–831. The most recent clinical guidelines provide a comprehensive approach to diagnosis and management of patients with hypertrophic cardiomyopathy. The role of multimodality imaging in diagnosis, management, risk stratification and intervention is highlighted.

    Article  PubMed  Google Scholar 

  3. Desai MY, Bhonsale A, Patel P, et al. Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes. JACC Cardiovasc Imaging. 2014;7(1):26–36. This paper highlights the role of exercise echocardiography in risk stratification in a large series of patients with hypertrophic cardiomyopathy and identifies exercise capacity and heart rate recovery after exercise as predictors of adverse events.

    Article  PubMed  Google Scholar 

  4. Peteiro J, Bouzas-Mosquera A, Fernandez X, et al. Prognostic value of exercise echocardiography in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2012;25:182–9.

    Article  PubMed  Google Scholar 

  5. Carasso S, Yang H, Woo A, et al. Systolic myocardial mechanics in hypertrophic cardiomyopathy: novel concepts and implications for clinical status. J Am Soc Echocardiogr. 2008;21(6):675–83.

    Article  PubMed  Google Scholar 

  6. Geske JB, Bos JM, Gersh BJ, Ommen SR, Eidem BW, Ackerman MJ. Deformation patterns in genotyped patients with hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2014;15(4):456–65.

    Article  PubMed  Google Scholar 

  7. Yang H, Carasso S, Woo A, et al. Hypertrophy pattern and regional myocardial mechanics are related in septal and apical hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2010;23(10):1081–9.

    Article  PubMed  Google Scholar 

  8. Urbano-Moral JA, Rowin EJ, Maron MS, Crean A, Pandian NG. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2014;7(1):11–9.

    Article  PubMed  Google Scholar 

  9. Saito M, Okayama H, Yoshii T, et al. Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2012;13(7):617–23.

    Article  PubMed  Google Scholar 

  10. Nagueh SF, Lakkis NM, Middleton KJ, Spencer III WH, Zoghbi WA, Quinones MA. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation. 1999;99(2):254–61.

    Article  CAS  PubMed  Google Scholar 

  11. Nishimura RA, Appleton CP, Redfield MM, Ilstrup DM, Holmes Jr DR, Tajik AJ. Noninvasive Doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study. J Am Coll Cardiol. 1996;28(5):1226–33.

    Article  CAS  PubMed  Google Scholar 

  12. Chen S, Yuan J, Qiao S, Duan F, Zhang J, Wang H. Evaluation of left ventricular diastolic function by global strain rate imaging in patients with obstructive hypertrophic cardiomyopathy: a simultaneous speckle tracking echocardiography and cardiac catheterization study. Echocardiography. 2014;31:615–22.

    Article  PubMed  Google Scholar 

  13. Garceau P, Carasso S, Woo A, Overgaard C, Schwartz L, Rakowski H. Evaluation of left ventricular relaxation and filling pressures in obstructive hypertrophic cardiomyopathy: comparison between invasive hemodynamics and two-dimensional speckle tracking. Echocardiography. 2012;29(8):934–42.

    Article  PubMed  Google Scholar 

  14. Carasso S, Yang H, Woo A, Jamorski M, Wigle ED, Rakowski H. Diastolic myocardial mechanics in hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2010;23(2):164–71.

    Article  PubMed  Google Scholar 

  15. Bruder O, Wagner A, Jensen CJ, et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010;56(11):875–87.

    Article  PubMed  Google Scholar 

  16. Conte MR, Bongioanni S, Chiribiri A, et al. Late gadolinium enhancement on cardiac magnetic resonance and phenotypic expression in hypertrophic cardiomyopathy. Am Heart J. 2011;161:1073–7.

    Article  CAS  PubMed  Google Scholar 

  17. Maron MS, Appelbaum E, Harrigan CJ, et al. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail. 2008;1:184–91.

    Article  PubMed  Google Scholar 

  18. Olivotto I, Maron BJ, Appelbaum E, et al. Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Am J Cardiol. 2010;106:261–7.

    Article  PubMed  Google Scholar 

  19. Adabag AS, Maron BJ, Appelbaum E, et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol. 2008;51(14):1369–74.

    Article  PubMed  Google Scholar 

  20. O’Hanlon R, Grasso A, Roughton M, et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010;56(11):867–74.

    Article  PubMed  Google Scholar 

  21. Chan RH, Maron BJ, Olivotto I, et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014;130(6):484–95.

    Article  PubMed  Google Scholar 

  22. Labombarda F, Pellissier A, Saloux E. Fibrosis suggested by 3D contrast-enhanced echocardiography in hypertrophic cardiomyopathy. Arch Cardiovasc Dis. 2011;104(12):680–1.

    Article  PubMed  Google Scholar 

  23. Almaas VM, Haugaa KH, Strom EH, et al. Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy. Heart. 2014;100(8):631–8.

    Article  PubMed  Google Scholar 

  24. Williams LK, Urbano-Moral JA, Rowin EJ, et al. Velocity vector imaging in the measurement of left ventricular myocardial mechanics on cardiac magnetic resonance imaging: correlations with echocardiographically derived strain values. J Am Soc Echocardiogr. 2013;26(10):1153–62.

    Article  PubMed  Google Scholar 

  25. Phelan D, Thavendiranathan P, Popovic Z, et al. Application of a parametric display of two-dimensional speckle-tracking longitudinal strain to improve the etiologic diagnosis of mild to moderate left ventricular hypertrophy. J Am Soc Echocardiogr. 2014;27(8):888–95. This paper highlights the role of strain maps obtained from speckle-tracking echocardiography as an accurate and reproducible means of differentiating the various conditions that manifest as unexplained left ventricular hypertrophy.

    Article  PubMed  Google Scholar 

  26. Liu D, Hu K, Niemann M, et al. Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy. Circ Cardiovasc Imaging. 2013;6(6):1066–72.

    Article  PubMed  Google Scholar 

  27. Phelan D, Collier P, Thavendiranathan P, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012;98(19):1442–8.

    Article  PubMed  Google Scholar 

  28. Kramer J, Niemann M, Liu D, et al. Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease. Eur Heart J. 2013;34:1587–96.

    Article  PubMed  Google Scholar 

  29. Sachdev V, Shizukuda Y, Brenneman CL, et al. Left atrial volumetric remodeling is predictive of functional capacity in nonobstructive hypertrophic cardiomyopathy. Am Heart J. 2005;149:730–6.

    Article  PubMed  Google Scholar 

  30. Nistri S, Olivotto I, Betocchi S, et al. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). Am J Cardiol. 2006;98:960–5.

    Article  PubMed  Google Scholar 

  31. Tani T, Yagi T, Kitai T et al. Left atrial volume predicts adverse cardiac and cerebrovascular events in patients with hypertrophic cardiomyopathy. Cardiovasc Ultrasound 9[34]. 2011.

  32. Yang W, Shim CY, Kim YJ, et al. Left atrial volume index: a predictor of adverse outcome in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2009;22:1338–43.

    Article  PubMed  Google Scholar 

  33. Maron BJ, Haas TS, Maron MS, et al. Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance. Am J Cardiol. 2014;113(8):1394–400. This paper demonstrates the abnormalities in left atrial volumes and left atrial ejection fraction in patients with HCM and their relation to the development of atrial fibrillation.

    Article  PubMed  Google Scholar 

  34. Rosca M, Popescu BA, Beladan CC, et al. Left atrial dysfunction as a correlate of heart failure symptoms in hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2010;23:1090–8.

    Article  PubMed  Google Scholar 

  35. Paraskevaidis IA, Farmakis D, Papadopoulos C, et al. Two-dimensional strain analysis in patients with hypertrophic cardiomyopathy and normal systolic function: a 12-month follow-up study. Am Heart J. 2009;158:444–50.

    Article  PubMed  Google Scholar 

  36. Lai EJ, Carasso S, Rakowski H et al. A CMR study of left atrial mechanics in hypertrophic cardiomyopathy: left atrial function predicts paroxysmal atrial fibrillation. Eur Heart J. 2013, 1;34(suppl 1).

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Lynne Williams, Christiane Gruner and Harry Rakowski declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Department of Cardiology, Papworth Hospital NHS Foundation Trust, Papworth Everard, CB23 3RE, UK

    Lynne K. Williams

  2. Division of Cardiology, Cardiovascular Center, University Hospital, Zurich, 8091, Switzerland

    Christiane H. Gruner

  3. Division of Cardiology, Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, Toronto, M5G 2C4, Canada

    Lynne K. Williams, Christiane H. Gruner & Harry Rakowski

Authors
  1. Lynne K. Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christiane H. Gruner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Harry Rakowski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lynne K. Williams.

Additional information

This article is part of the Topical Collection on Echocardiography

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Williams, L.K., Gruner, C.H. & Rakowski, H. The Role of Echocardiography in Hypertrophic Cardiomyopathy. Curr Cardiol Rep 17, 6 (2015). https://doi.org/10.1007/s11886-014-0560-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-014-0560-x

Keywords

Search

Navigation